Dextenza intraocular and Lantus Solostar (Insulin Glargine (U-300) Pens)
Determining the interaction of Dextenza intraocular and Lantus Solostar (Insulin Glargine (U-300) Pens) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular), Dextenza Insert
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextenza intraocular-Lantus Solostar Pen
- Dextenza intraocular-Lapatinib
- Dextenza intraocular-Lapatinib Ditosylate
- Dextenza intraocular-Lariam
- Dextenza intraocular-Larin 1.5/30
- Dextenza intraocular-Larin 1/20
- Lantus Solostar (Insulin Glargine (U-300) Pens)-Dextran 40
- Lantus Solostar (Insulin Glargine (U-300) Pens)-Dextran 70 6% in 5% Dextrose high molecular weight
- Lantus Solostar (Insulin Glargine (U-300) Pens)-Dextran 75
- Lantus Solostar (Insulin Glargine (U-300) Pens)-Dextran high molecular weight
- Lantus Solostar (Insulin Glargine (U-300) Pens)-Dextranomer and Hyaluronate Derivatives (Deflux)
- Lantus Solostar (Insulin Glargine (U-300) Pens)-Dextranomer and Hyaluronate Derivatives (Solesta)